The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other…
Robert Galbraith | ReutersThe Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move that could have ramifications for a string of…